Page last updated: 2024-12-06
nitracrine
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
Nitracrine: Acridine antineoplastic agent used in mammary and ovarian tumors. It inhibits RNA synthesis. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 20628 |
CHEMBL ID | 26291 |
CHEBI ID | 135384 |
SCHEMBL ID | 8807 |
MeSH ID | M0014872 |
Synonyms (31)
Synonym |
---|
1-nitro-9-(3'-dimethylaminopropylamino)-acridine |
nitracrina [inn-spanish] |
ccris 1973 |
acridine, 9-(3-(dimethylamino)propylamino)-1-nitro- |
1-nitro-9-(dimethylaminopropylamino)acridine |
nitracrine [inn] |
1,3-propanediamine, n,n-dimethyl-n'-(1-nitro-9-acridinyl)- |
nitracrinum [inn-latin] |
9-((3-(dimethylamino)propyl)amino)-1-nitroacridine |
nitracrine |
1,3-propanediamine, n,n-dimethyl-n'-(1-nitro-9-acridinyl)-, dihydrochloride |
9-((3-(dimethylamino)propyl)amino)-1-(hydroxy(oxido)amino)acridine |
ledacrine |
n',n'-dimethyl-n-(1-nitroacridin-9-yl)propane-1,3-diamine |
nsc247561 |
NCI60_001977 |
CHEBI:135384 |
CHEMBL26291 |
4533-39-5 |
nitracrina |
nitracrinum |
712mlz30sb , |
unii-712mlz30sb |
nitracrine [mi] |
SCHEMBL8807 |
DTXSID90196481 |
CS-7229 |
HY-U00279 |
Q27265916 |
n,n-dimethyl-n'-(1-nitro-acridin-9-yl)-propane-1,3-diamine |
AKOS040742305 |
Research Excerpts
Overview
Nitracrine (Ledakrin) is an antitumor drug which is activated by cellular enzymes and binds covalently to DNA. Nitracrine is an electron affinic DNA intercalating agent and a potent hypoxia-selective cytotoxin and radiosensitizer in cell culture.
Excerpt | Reference | Relevance |
---|---|---|
"Nitracrine (Ledakrin) is an antitumor drug which is activated by cellular enzymes and binds covalently to DNA. " | ( Modulation of G(2) arrest enhances cell death induced by the antitumor 1-nitroacridine derivative, Nitracrine. Skladanowski, A, 2002) | 1.97 |
"Nitracrine (NC) is an electron affinic DNA intercalating agent and a potent hypoxia-selective cytotoxin and radiosensitizer in cell culture. " | ( The reaction between nitracrine and glutathione: implications for hypoxic cell radiosensitization and cytotoxicity. Anderson, RF; Wilson, WR, 1989) | 2.04 |
Treatment
Excerpt | Reference | Relevance |
---|---|---|
"Nitracrine treatment with biologically relevant concentrations (0.1-3.0 microM, 1 hr, 37 degrees) induced only DPCs." | ( Are lethal effects of nitracrine on L5178Y cell sublines associated with DNA-protein crosslinks? Ciesielska, E; Gradzka, I; Szmigiero, L; Walicka, M, 1993) | 1.32 |
Toxicity
Compound-Compound Interactions
Excerpt | Reference | Relevance |
---|---|---|
" The present studies aimed to know its biotransformation with phase II enzymes - UDP-glucuronosyltransferases (UGTs) and its potential to be engaged in drug-drug interactions arising from the modulation of UGT activity." | ( Drug-drug interaction potential of antitumor acridine agent C-1748: The substrate of UDP-glucuronosyltransferases 2B7, 2B17 and the inhibitor of 1A9 and 2B7. Bejrowska, A; Mazerska, Z; Mróz, A; Ryska, I; Sominko, H, 2018) | 0.48 |
"The observed UGT-mediated metabolism of C-1748 and its ability to inhibit UGT activity should be considered as the potency for drug resistance and drug-drug interactions in the prospective multidrug therapy." | ( Drug-drug interaction potential of antitumor acridine agent C-1748: The substrate of UDP-glucuronosyltransferases 2B7, 2B17 and the inhibitor of 1A9 and 2B7. Bejrowska, A; Mazerska, Z; Mróz, A; Ryska, I; Sominko, H, 2018) | 0.48 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Drug Classes (1)
Class | Description |
---|---|
acridines | |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Bioassays (52)
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID25229 | Extrapolated fraction of biological activity remaining at time zero of hypoxic AA8 suspension cultures | 1989 | Journal of medicinal chemistry, Jan, Volume: 32, Issue:1 | Hypoxia-selective antitumor agents. 2. Electronic effects of 4-substituents on the mechanisms of cytotoxicity and metabolic stability of nitracrine derivatives. |
AID25358 | Compound was evaluated for quinoline pKa value in aqueous solution at 25 degree Celsius by spectrophotometry | 1992 | Journal of medicinal chemistry, Dec-25, Volume: 35, Issue:26 | Hypoxia-selective antitumor agents. 6. 4-(Alkylamino)nitroquinolines: a new class of hypoxia-selective cytotoxins. |
AID231784 | Ratio of concentration required to reduce cell (AA8) survival by 10% under aerobic to hypoxic (air/N2) conditions. | 1992 | Journal of medicinal chemistry, Dec-25, Volume: 35, Issue:26 | Hypoxia-selective antitumor agents. 6. 4-(Alkylamino)nitroquinolines: a new class of hypoxia-selective cytotoxins. |
AID45253 | Ratio of cytotoxicity determined in air to that of cytotoxicity determined in N2 was measured under aerobic conditions to hypoxic conditions by the clonogenic assay against Chinese hamster ovary (subline AA8) cells | 1989 | Journal of medicinal chemistry, Jan, Volume: 32, Issue:1 | Hypoxia-selective antitumor agents. 1. Relationships between structure, redox properties and hypoxia-selective cytotoxicity for 4-substituted derivatives of nitracrine. |
AID215282 | Inhibitory concentration required to reduce cell density in UV-4 cells to 50% of controls (cells were exposed to compound for 4 days continuously) | 1989 | Journal of medicinal chemistry, Jan, Volume: 32, Issue:1 | Hypoxia-selective antitumor agents. 2. Electronic effects of 4-substituents on the mechanisms of cytotoxicity and metabolic stability of nitracrine derivatives. |
AID115154 | Maximum tolerated ip dose for male C3H/HeN mice. | 1996 | Journal of medicinal chemistry, Jun-21, Volume: 39, Issue:13 | Hypoxia-selective antitumor agents. 13. Effects of acridine substitution on the hypoxia-selective cytotoxicity and metabolic reduction of the bis-bioreductive agent nitracrine N-oxide. |
AID25329 | Acridine pKa values were determined in aqueous solution at 25 degrees Centigrade by spectrophotometric method. | 1990 | Journal of medicinal chemistry, May, Volume: 33, Issue:5 | Hypoxia-selective antitumor agents. 4. Relationships between structure, physicochemical properties, and hypoxia-selective cytotoxicity for nitracrine analogues with varying side chains: the "iminoacridan hypothesis". |
AID55130 | Logarithm of association constant for binding to poly[d(A-T)], determined by ethidium displacement | 1989 | Journal of medicinal chemistry, Jan, Volume: 32, Issue:1 | Hypoxia-selective antitumor agents. 1. Relationships between structure, redox properties and hypoxia-selective cytotoxicity for 4-substituted derivatives of nitracrine. |
AID232184 | Ratio of concentrations inhibiting AA8 cell growth (18 hr exposure) under aerobic (air) and hypoxic (air/N2) conditions | 1992 | Journal of medicinal chemistry, Dec-25, Volume: 35, Issue:26 | Hypoxia-selective antitumor agents. 6. 4-(Alkylamino)nitroquinolines: a new class of hypoxia-selective cytotoxins. |
AID9675 | CT10 (air/N2) ratio of the product of the drug concentration to the exposure time needed to reduce cell survival to 10% of controls using AA8 cells at 10 E 6 /mL in the clonogenic assay | 1990 | Journal of medicinal chemistry, May, Volume: 33, Issue:5 | Hypoxia-selective antitumor agents. 4. Relationships between structure, physicochemical properties, and hypoxia-selective cytotoxicity for nitracrine analogues with varying side chains: the "iminoacridan hypothesis". |
AID9837 | Growth inhibitory activity against CHO subline AA8 cells exposed for 18 hr under aerobic conditions | 1992 | Journal of medicinal chemistry, Dec-25, Volume: 35, Issue:26 | Hypoxia-selective antitumor agents. 6. 4-(Alkylamino)nitroquinolines: a new class of hypoxia-selective cytotoxins. |
AID215156 | Trypanocidal activity against Trypanosoma brucei, exposure of parasites to compound prior to injection into mice at 10 e-5 M concentration in presence of light | 1984 | Journal of medicinal chemistry, Jul, Volume: 27, Issue:7 | Identification of an acridine photoaffinity probe for trypanocidal action. |
AID25570 | Dissociation constant of the compound | 1989 | Journal of medicinal chemistry, Jan, Volume: 32, Issue:1 | Hypoxia-selective antitumor agents. 1. Relationships between structure, redox properties and hypoxia-selective cytotoxicity for 4-substituted derivatives of nitracrine. |
AID215159 | Trypanocidal activity against Trypanosoma brucei, exposure of parasites to compound prior to injection into mice at 10 e-6 M concentration in dark conditions | 1984 | Journal of medicinal chemistry, Jul, Volume: 27, Issue:7 | Identification of an acridine photoaffinity probe for trypanocidal action. |
AID9650 | Inhibitory activity against aerobic growth of AA8 cells. | 1996 | Journal of medicinal chemistry, Jun-21, Volume: 39, Issue:13 | Hypoxia-selective antitumor agents. 13. Effects of acridine substitution on the hypoxia-selective cytotoxicity and metabolic reduction of the bis-bioreductive agent nitracrine N-oxide. |
AID45746 | Inhibitory activity to reduce cell density by 50% of AA8 cells under aerobic conditions | 1989 | Journal of medicinal chemistry, Jan, Volume: 32, Issue:1 | Hypoxia-selective antitumor agents. 2. Electronic effects of 4-substituents on the mechanisms of cytotoxicity and metabolic stability of nitracrine derivatives. |
AID226471 | Hypersensitivity factor, IC50 (AA8) air /IC50 (UV4) in N2 | 1990 | Journal of medicinal chemistry, May, Volume: 33, Issue:5 | Hypoxia-selective antitumor agents. 4. Relationships between structure, physicochemical properties, and hypoxia-selective cytotoxicity for nitracrine analogues with varying side chains: the "iminoacridan hypothesis". |
AID228707 | Compound's one-electron reduction potential (E(1)) has been measured by radiolysis at pK1 | 1989 | Journal of medicinal chemistry, Jan, Volume: 32, Issue:1 | Hypoxia-selective antitumor agents. 1. Relationships between structure, redox properties and hypoxia-selective cytotoxicity for 4-substituted derivatives of nitracrine. |
AID214997 | Trypanocidal activity against Trypanosoma brucei, exposure of parasites to compound prior to injection into mice at 10 e-4 M concentration in presence of light | 1984 | Journal of medicinal chemistry, Jul, Volume: 27, Issue:7 | Identification of an acridine photoaffinity probe for trypanocidal action. |
AID226472 | Hypersensitivity factor, IC50 (AA8) air /IC50 (UV4) in air | 1990 | Journal of medicinal chemistry, May, Volume: 33, Issue:5 | Hypoxia-selective antitumor agents. 4. Relationships between structure, physicochemical properties, and hypoxia-selective cytotoxicity for nitracrine analogues with varying side chains: the "iminoacridan hypothesis". |
AID9477 | Concentration needed to reduce cell survival to 10% of control values, using 1 hour exposure of plateau phase AA8 cells at 10e6 cells/ml | 1996 | Journal of medicinal chemistry, Jun-21, Volume: 39, Issue:13 | Hypoxia-selective antitumor agents. 13. Effects of acridine substitution on the hypoxia-selective cytotoxicity and metabolic reduction of the bis-bioreductive agent nitracrine N-oxide. |
AID215158 | Compound is evaluated for trypanocidal activity against Trypanosoma brucei, by exposing the parasites directly to compound prior to injection to mice at 10 e-6 M concentration (pre) in presence of light. | 1984 | Journal of medicinal chemistry, Jul, Volume: 27, Issue:7 | Identification of an acridine photoaffinity probe for trypanocidal action. |
AID47694 | Inhibitory activity of compound for AA8 cells to reduce cell density by 50% (exposed to compound for 4 hours) | 1989 | Journal of medicinal chemistry, Jan, Volume: 32, Issue:1 | Hypoxia-selective antitumor agents. 2. Electronic effects of 4-substituents on the mechanisms of cytotoxicity and metabolic stability of nitracrine derivatives. |
AID27042 | Half life of extracellular bioactivity assessed by bioassay of culture supernatant against hypoxic UV-4 cells | 1989 | Journal of medicinal chemistry, Jan, Volume: 32, Issue:1 | Hypoxia-selective antitumor agents. 2. Electronic effects of 4-substituents on the mechanisms of cytotoxicity and metabolic stability of nitracrine derivatives. |
AID215154 | Trypanocidal activity against Trypanosoma brucei, exposure of parasites to compound prior to injection into mice at 10 e-5 M concentration in dark conditions | 1984 | Journal of medicinal chemistry, Jul, Volume: 27, Issue:7 | Identification of an acridine photoaffinity probe for trypanocidal action. |
AID232183 | Ratio of growth inhibitory concentrations against AA8 cells and UV4 cells exposed to the compound for 18 hr under aerobic(air) conditions | 1992 | Journal of medicinal chemistry, Dec-25, Volume: 35, Issue:26 | Hypoxia-selective antitumor agents. 6. 4-(Alkylamino)nitroquinolines: a new class of hypoxia-selective cytotoxins. |
AID9838 | Tested for the concentration of the drug to reduce cell numbers to 50 percent of controls against AA8 cells in the microassay | 1990 | Journal of medicinal chemistry, May, Volume: 33, Issue:5 | Hypoxia-selective antitumor agents. 4. Relationships between structure, physicochemical properties, and hypoxia-selective cytotoxicity for nitracrine analogues with varying side chains: the "iminoacridan hypothesis". |
AID230206 | Inhibitory activity against aerobic growth of UV4cells, Hypersensitivity factor is the ratio of IC50(AA8) to IC50(UV4). | 1996 | Journal of medicinal chemistry, Jun-21, Volume: 39, Issue:13 | Hypoxia-selective antitumor agents. 13. Effects of acridine substitution on the hypoxia-selective cytotoxicity and metabolic reduction of the bis-bioreductive agent nitracrine N-oxide. |
AID229914 | Spheroid resistance factor which is defined as the ratio C10 (intact)/ C10 (dissociated) EMT6 cells | 1996 | Journal of medicinal chemistry, Jun-21, Volume: 39, Issue:13 | Hypoxia-selective antitumor agents. 13. Effects of acridine substitution on the hypoxia-selective cytotoxicity and metabolic reduction of the bis-bioreductive agent nitracrine N-oxide. |
AID16679 | Equilibrium constant measured by the pulse radiolysis at pH 7 | 1989 | Journal of medicinal chemistry, Jan, Volume: 32, Issue:1 | Hypoxia-selective antitumor agents. 1. Relationships between structure, redox properties and hypoxia-selective cytotoxicity for 4-substituted derivatives of nitracrine. |
AID215162 | Compound is evaluated for trypanocidal activity against Trypanosoma brucei, by exposing the parasites directly to compound prior to injection to mice at 10 e-7 M concentration in dark conditions | 1984 | Journal of medicinal chemistry, Jul, Volume: 27, Issue:7 | Identification of an acridine photoaffinity probe for trypanocidal action. |
AID9674 | Tested for the product of the drug concentration to the exposure time needed to reduce cell survival to 10% of controls using AA8 cells at 10 E 6 /mL in the clonogenic assay | 1990 | Journal of medicinal chemistry, May, Volume: 33, Issue:5 | Hypoxia-selective antitumor agents. 4. Relationships between structure, physicochemical properties, and hypoxia-selective cytotoxicity for nitracrine analogues with varying side chains: the "iminoacridan hypothesis". |
AID228706 | Compound''s one-electron reduction potential (E(1)) has been measured by radiolysis at pH 7 | 1989 | Journal of medicinal chemistry, Jan, Volume: 32, Issue:1 | Hypoxia-selective antitumor agents. 1. Relationships between structure, redox properties and hypoxia-selective cytotoxicity for 4-substituted derivatives of nitracrine. |
AID9672 | Concentration required to reduce AA8 cell survival by 10% | 1992 | Journal of medicinal chemistry, Dec-25, Volume: 35, Issue:26 | Hypoxia-selective antitumor agents. 6. 4-(Alkylamino)nitroquinolines: a new class of hypoxia-selective cytotoxins. |
AID27040 | Half life of extracellular bioactivity assessed by bioassay of culture supernatant against aerobic UV-4 cells | 1989 | Journal of medicinal chemistry, Jan, Volume: 32, Issue:1 | Hypoxia-selective antitumor agents. 2. Electronic effects of 4-substituents on the mechanisms of cytotoxicity and metabolic stability of nitracrine derivatives. |
AID25230 | Extrapolated fraction of biological activity remaining at time zero of stirred aerobic AA8 suspension cultures | 1989 | Journal of medicinal chemistry, Jan, Volume: 32, Issue:1 | Hypoxia-selective antitumor agents. 2. Electronic effects of 4-substituents on the mechanisms of cytotoxicity and metabolic stability of nitracrine derivatives. |
AID215160 | Trypanocidal activity against Trypanosoma brucei, exposur of parasites to compound prior to injection into mice at 10 e-6 M concentration in presence of light | 1984 | Journal of medicinal chemistry, Jul, Volume: 27, Issue:7 | Identification of an acridine photoaffinity probe for trypanocidal action. |
AID229743 | Hypersensitivity factor (HF) of IC50 (AA8) / IC50 (UV-5) of compound for repair deffective mutants | 1989 | Journal of medicinal chemistry, Jan, Volume: 32, Issue:1 | Hypoxia-selective antitumor agents. 2. Electronic effects of 4-substituents on the mechanisms of cytotoxicity and metabolic stability of nitracrine derivatives. |
AID27864 | Total compound concentration in AA8 suspension cultures at zero time | 1989 | Journal of medicinal chemistry, Jan, Volume: 32, Issue:1 | Hypoxia-selective antitumor agents. 2. Electronic effects of 4-substituents on the mechanisms of cytotoxicity and metabolic stability of nitracrine derivatives. |
AID67616 | Concentration resulting in 10% survival in dissociated EMT6 spheroid cell suspension | 1996 | Journal of medicinal chemistry, Jun-21, Volume: 39, Issue:13 | Hypoxia-selective antitumor agents. 13. Effects of acridine substitution on the hypoxia-selective cytotoxicity and metabolic reduction of the bis-bioreductive agent nitracrine N-oxide. |
AID214996 | Trypanocidal activity against Trypanosoma brucei, exposure of parasites to compound prior to injection into mice at 10 e-4 M concentration in dark conditions | 1984 | Journal of medicinal chemistry, Jul, Volume: 27, Issue:7 | Identification of an acridine photoaffinity probe for trypanocidal action. |
AID232180 | Ratio of growth inhibition of compound to reduce cell density by 50% of AA8 cells under aerobic and hypoxic conditions (air/N2) | 1989 | Journal of medicinal chemistry, Jan, Volume: 32, Issue:1 | Hypoxia-selective antitumor agents. 2. Electronic effects of 4-substituents on the mechanisms of cytotoxicity and metabolic stability of nitracrine derivatives. |
AID229742 | Hypersensitivity factor (HF) of IC50 (AA8) / IC50 (UV-4) of compound for repair deffective mutants | 1989 | Journal of medicinal chemistry, Jan, Volume: 32, Issue:1 | Hypoxia-selective antitumor agents. 2. Electronic effects of 4-substituents on the mechanisms of cytotoxicity and metabolic stability of nitracrine derivatives. |
AID211493 | Cytotoxicity was measured under aerobic conditions by the clonogenic assay against Chinese hamster ovary (subline AA8) cells | 1989 | Journal of medicinal chemistry, Jan, Volume: 32, Issue:1 | Hypoxia-selective antitumor agents. 1. Relationships between structure, redox properties and hypoxia-selective cytotoxicity for 4-substituted derivatives of nitracrine. |
AID229741 | Hypersensitivity factor (HF) of IC50 (AA8) / IC50 (EM-9) of compound for repair deffective mutants | 1989 | Journal of medicinal chemistry, Jan, Volume: 32, Issue:1 | Hypoxia-selective antitumor agents. 2. Electronic effects of 4-substituents on the mechanisms of cytotoxicity and metabolic stability of nitracrine derivatives. |
AID215281 | Inhibitory ativity to reduce cell density by 50% of repair deffective mutant UV-4 cells in 96-well cultures under aerobic conditions | 1989 | Journal of medicinal chemistry, Jan, Volume: 32, Issue:1 | Hypoxia-selective antitumor agents. 2. Electronic effects of 4-substituents on the mechanisms of cytotoxicity and metabolic stability of nitracrine derivatives. |
AID231942 | Ratio for hypoxic AA8/ hypoxic UV-4, expressed as hypersensitivity factor under aerobic conditions | 1989 | Journal of medicinal chemistry, Jan, Volume: 32, Issue:1 | Hypoxia-selective antitumor agents. 2. Electronic effects of 4-substituents on the mechanisms of cytotoxicity and metabolic stability of nitracrine derivatives. |
AID215163 | Compound is evaluated for trypanocidal activity against Trypanosoma brucei, by exposing the parasites directly to compound prior to injection to mice at 10 e-7 M concentration in presence of light | 1984 | Journal of medicinal chemistry, Jul, Volume: 27, Issue:7 | Identification of an acridine photoaffinity probe for trypanocidal action. |
AID232181 | Ratio of growth inhibition of compound to reduce cell density by 50% of repair deffective mutant UV-4 cells in 96-well cultures under aerobic and hypoxic conditions (air/N2) | 1989 | Journal of medicinal chemistry, Jan, Volume: 32, Issue:1 | Hypoxia-selective antitumor agents. 2. Electronic effects of 4-substituents on the mechanisms of cytotoxicity and metabolic stability of nitracrine derivatives. |
AID20518 | Relative lipophilicity of the compound | 1989 | Journal of medicinal chemistry, Jan, Volume: 32, Issue:1 | Hypoxia-selective antitumor agents. 1. Relationships between structure, redox properties and hypoxia-selective cytotoxicity for 4-substituted derivatives of nitracrine. |
AID233733 | Air/N2 ratio = C10(air)/C10(nitrogen) | 1996 | Journal of medicinal chemistry, Jun-21, Volume: 39, Issue:13 | Hypoxia-selective antitumor agents. 13. Effects of acridine substitution on the hypoxia-selective cytotoxicity and metabolic reduction of the bis-bioreductive agent nitracrine N-oxide. |
AID9840 | IC50 (air/N2) ratio of the drug to reduce cell numbers to 50 percent of controls using AA8 cells in the microassay | 1990 | Journal of medicinal chemistry, May, Volume: 33, Issue:5 | Hypoxia-selective antitumor agents. 4. Relationships between structure, physicochemical properties, and hypoxia-selective cytotoxicity for nitracrine analogues with varying side chains: the "iminoacridan hypothesis". |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (109)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 62 (56.88) | 18.7374 |
1990's | 23 (21.10) | 18.2507 |
2000's | 14 (12.84) | 29.6817 |
2010's | 9 (8.26) | 24.3611 |
2020's | 1 (0.92) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 18.60
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (18.60) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 2 (1.48%) | 5.53% |
Reviews | 2 (1.48%) | 6.00% |
Case Studies | 1 (0.74%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 130 (96.30%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |